Cargando...
The value of hepatic resection in metastasic renal cancer in the Era of Tyrosinkinase Inhibitor Therapy
BACKGROUND: The value of liver-directed therapy (LDT) in patients with metastasic renal cell carcinoma (MRCC) is still an active field of research, particularly in the era of tyrosinkinase inhibitor (TKI) therapy. METHODS: The records of 35 patients with MRCC undergoing LDT of metastasic liver lesio...
Guardado en:
| Publicado en: | BMC Surg |
|---|---|
| Autores principales: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4957271/ https://ncbi.nlm.nih.gov/pubmed/27444582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12893-016-0163-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|